BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 759567)

  • 1. Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection.
    Freed CR; Asmus PA
    J Neurochem; 1979 Jan; 32(1):163-8. PubMed ID: 759567
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical lonization mass spectrometric measurement of alpha-methyldopa and s-dopa metabolites in rat brain regions.
    Freed CR; Weinkam RJ; Melmon KL; Castagnoli N
    Anal Biochem; 1977 Apr; 78(2):319-32. PubMed ID: 851208
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dopa metabolism in relation to the therapy of Parkinson's syndrome].
    Pletscher A; Bartholini G
    Actual Pharmacol (Paris); 1971; 24():27-49. PubMed ID: 5150621
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of free DOPA and 3-O-methyl-DOPA in human plasma by high-performance liquid chromatography with electrochemical detection.
    Melzi d'Eril GV; Rizzo V
    J Chromatogr; 1991 Aug; 553(1-2):265-9. PubMed ID: 1787158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for tyrosine hydroxylase in hypothalamic homogenates using high-performance liquid chromatography with electrochemical detection.
    Philipp E
    J Chromatogr; 1987 Aug; 419():27-36. PubMed ID: 2889743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of L-aromatic amino acid decarboxylase by high performance liquid chromatography.
    D'Erme M; Rosei MA; Fiori A; Di Stazio G
    Anal Biochem; 1980 May; 104(1):59-61. PubMed ID: 6770716
    [No Abstract]   [Full Text] [Related]  

  • 8. 3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier.
    Wade LA; Katzman R
    Life Sci; 1975 Jul; 17(1):131-6. PubMed ID: 1143006
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

  • 10. A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.
    Curzon G; Kantamaneni BD; Trigwell J
    Clin Chim Acta; 1972 Mar; 37():335-41. PubMed ID: 5022098
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease.
    Sharpless NS; Muenter MD; Tyce GM; Owen CA
    Clin Chim Acta; 1972 Mar; 37():359-69. PubMed ID: 5022100
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
    Geissbühler F; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Clin Chim Acta; 1971 Jun; 33(1):111-5. PubMed ID: 5097993
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous determination of L-dopa and 3-O-methyldopa in human serum by high-performance liquid chromatography.
    Beers MF; Stern M; Hurtig H; Melvin G; Scarpa A
    J Chromatogr; 1984 Dec; 336(2):380-4. PubMed ID: 6442301
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinsonism treated with 3-O-methyldopa.
    Calne DB; Reid JL; Vakil SD
    Clin Pharmacol Ther; 1973; 14(3):386-9. PubMed ID: 4698566
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of L-dopa in patients with Parkinson's disease.
    Mena MA; Muradas V; Bazan E; Reiriz J; de Yebenes JG
    Adv Neurol; 1987; 45():481-6. PubMed ID: 2950730
    [No Abstract]   [Full Text] [Related]  

  • 18. Simple automated high-performance liquid chromatographic column-switching technique for the measurement of dopa and 3-O-methyldopa in plasma.
    Zürcher G; Da Prada M
    J Chromatogr; 1990 Sep; 530(2):253-62. PubMed ID: 2127780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
    Fahn S; Prasad AL; Delesie R
    Anal Biochem; 1972 Apr; 46(2):557-75. PubMed ID: 4337048
    [No Abstract]   [Full Text] [Related]  

  • 20. Incorporation of L-dopa, L-alpha-methyldopa and DL-isoproterenol into guinea pig hair.
    Harrison WH; Gray RM; Solomon LM
    Acta Derm Venereol; 1974; 54(4):249-53. PubMed ID: 4136810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.